Know Cancer

or
forgot password

Calcifidol Therapy in Men With Cancer


Phase 2
N/A
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Calcifidol Therapy in Men With Cancer

Inclusion Criteria


Patients will be males with three successive rises in PSA after achieving a nadir
post-definitive therapy. The following criteria must be met: pathologically confirmed
prostate cancer, completion of definitive treatment in the form of local external beam
radiation or definitive surgery and three successive rises in PSA with no clinical
evidence of disease.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Guy Howard, Ph.D

Authority:

United States: Federal Government

Study ID:

ONCO-09-99S

NCT ID:

NCT00018538

Start Date:

October 1999

Completion Date:

September 2002

Related Keywords:

  • Prostate Cancer
  • vitamin D
  • prostatic neoplasms
  • neoplasm recurrence
  • Prostatic Neoplasms

Name

Location

VAMC Miami, FLMiami, Florida  33125